Anesthetic Management for Left Ventricular Assist Device Implantation Without Using Cardiopulmonary Bypass: Case Series

Basit Öğe Kaydı
dc.contributor.authorKaraca, N.
dc.contributor.authorSahutoglu, C.
dc.contributor.authorKocabas, S.
dc.contributor.authorOrhaner, B. T.
dc.contributor.authorAskar, F. Z.
dc.contributor.authorErtugay, S.
dc.contributor.authorEngin, C.
dc.contributor.authorYagdi, T.
dc.contributor.authorOzbaran, M.
dc.date.accessioned2019-10-27T22:26:45Z
dc.date.available2019-10-27T22:26:45Z
dc.date.issued2015
dc.departmentEge Üniversitesien_US
dc.description.abstractPurpose. Ventricular assist devices are an alternative to medical treatment in patients with hemodynamic disturbances related to acute or chronic congestive heart failure. In this case series, we present our anesthesia management for implantation of left ventricular assist device (LVAD) with thoracotomy. Method. Sixteen patients with end-stage heart failure undergoing LVAD implantation via thoracotomy between November 2012 and August 2014 were analyzed prospectively. Preoperative characteristics, intraoperative hemodynamic and respiratory parameters, use of anesthetic and blood products, and durations of mechanical ventilation, hospital, and intensive care stays were recorded. Results. Sixteen patients (mean age, 54.6 +/- 13 years) were investigated. Single-lung ventilation was applied to 2 patients. Cardiopulmonary bypass (CPB) was required in 5 patients. Intraoperative ketamine, midazolam, fentanyl, and rocuronium requirements were 112 +/- 63 mg, 5.5 +/- 3.5 mg, 438 +/- 187 mu g, and 179 +/- 49 mg, respectively. Requirements of fresh donor blood, fresh frozen plasma, and thrombocyte and erythrocyte suspension were 1.19 +/- 1, 1 +/- 0.8, 0.44 +/- 0.5, and 0.25 +/- 0.7 U, respectively. Durations of mechanical ventilation, intensive care unit, and hospital stay were 46 53 hours, 8.2 +/- 6.6 days, and 20.5 +/- 11.6 days, respectively. Twelve patients were discharged from hospital with full recovery and 2 patients died; 2 patients are still receiving treatment in the hospital. Conclusion. A left thoracotomy approach can be used without CPB, because it reduces the incidences of pump complications and blood transfusion. In addition, this case series showed that the implantation of LVAD by thoracotomy can be implemented securely with single-lumen endotracheal tube without single-lung ventilation.en_US
dc.identifier.doi10.1016/j.transproceed.2015.04.074en_US
dc.identifier.endpage1506en_US
dc.identifier.issn0041-1345
dc.identifier.issn1873-2623
dc.identifier.issue5en_US
dc.identifier.pmid26093752en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage1503en_US
dc.identifier.urihttps://doi.org/10.1016/j.transproceed.2015.04.074
dc.identifier.urihttps://hdl.handle.net/11454/50420
dc.identifier.volume47en_US
dc.identifier.wosWOS:000357066800064en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofTransplantation Proceedingsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleAnesthetic Management for Left Ventricular Assist Device Implantation Without Using Cardiopulmonary Bypass: Case Seriesen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu